Yes, Demerol (meperidine) is a Schedule II controlled substance in the United States, placing it in the same category as morphine, oxycodone, and fentanyl. Schedule II is the most restrictive classification for drugs that still have accepted medical uses, meaning Demerol carries a high potential for abuse that can lead to severe physical or psychological dependence.
What Schedule II Means in Practice
The Drug Enforcement Administration assigns controlled substances to one of five schedules based on three factors: whether the drug has a legitimate medical use, how likely it is to be abused, and how easily it causes dependence. Schedule II sits at the top of the risk scale for drugs that doctors can still prescribe. In practical terms, this means Demerol prescriptions cannot be refilled. Each fill requires a new prescription, and in most states that prescription must be written (not called in) or transmitted electronically with specific security features.
Internationally, meperidine (known outside the U.S. as pethidine) is listed under Schedule I of the United Nations Single Convention on Narcotic Drugs, which imposes the strictest international controls on its production, trade, and distribution.
Why Demerol Is Classified This Way
Demerol is a synthetic opioid that works on the same receptors in the brain as morphine. The FDA describes its abuse liability as “similar to morphine,” though it is a weaker painkiller overall. It takes roughly 75 mg of injected Demerol to match the pain relief of 10 mg of injected morphine. That lower potency doesn’t reduce its addiction risk. The drug produces the same cycle of tolerance and physical dependence seen with other opioids: over time, higher doses are needed to achieve the same effect, and stopping abruptly triggers withdrawal.
Withdrawal symptoms follow a predictable pattern. Early signs include agitation, anxiety, muscle aches, excessive tearing, sweating, yawning, and insomnia. Later symptoms escalate to abdominal cramping, diarrhea, nausea, vomiting, and dilated pupils. Because of this, opioids used regularly should be tapered gradually rather than stopped all at once.
Risks That Set Demerol Apart From Other Opioids
Demerol carries several risks that are unique among commonly prescribed opioids, which is why its use has declined significantly over the past two decades.
The biggest concern is a toxic byproduct. When your body breaks down meperidine, it produces a metabolite that can build up and damage the nervous system. This buildup causes symptoms ranging from anxiety and tremors to muscle twitching and full seizures. The standard opioid-reversal treatment does not reverse this specific type of toxicity. In people with kidney problems, this byproduct lingers far longer (its half-life stretches to about 34 hours), making the risk of nerve toxicity much higher. Even people with normal kidney function have experienced seizures at relatively modest doses given over just a few days.
Demerol also has a dangerous interaction with a class of antidepressants called MAO inhibitors. Taking Demerol while on an MAO inhibitor, or within 14 days of stopping one, can trigger life-threatening reactions including severe respiratory depression, extremely high body temperature, seizures, and coma. This interaction is so serious that it is listed as an absolute contraindication, not just a warning.
FDA Warnings on the Label
Demerol’s FDA label carries multiple boxed warnings, the most serious type of safety alert the agency issues. These cover:
- Addiction, abuse, and misuse that can lead to overdose and death
- Respiratory depression that can be life-threatening, particularly when starting the drug or increasing the dose
- Dangerous interactions with benzodiazepines, alcohol, and other sedating drugs, which can cause profound sedation, respiratory failure, coma, and death
- Accidental ingestion by children, which can be fatal
- Neonatal withdrawal syndrome in babies born to mothers who used the drug during pregnancy
- Dosing errors between the tablet and liquid forms, since confusion between milligrams and milliliters has caused accidental overdoses
How Demerol Is Still Used
Demerol is available as 50 mg and 100 mg tablets, a banana-flavored oral liquid (10 mg per milliliter), and injectable forms used in hospitals. Its medical use has narrowed considerably. Many hospitals have restricted or removed it from their formularies because of the seizure risk and the availability of safer opioid alternatives. When it is used today, it tends to be limited to short courses, often for post-procedural shivering or as a brief pain treatment in patients who cannot tolerate other opioids.
The Veterans Health Administration, for example, has established strict criteria limiting meperidine use and specifically warns against repeated dosing. The neurotoxic effects from its byproduct have been documented in as little as 17 hours of use at higher doses, making prolonged treatment particularly risky.